Skip to main content
Review

Scoping review of studies evaluating frailty and its association with medication harm.

Lam JYJ, Barras M, Scott IA, et al. Scoping review of studies evaluating frailty and its association with medication harm. Drugs Aging. 2022;39(5):333-353. doi: 10.1007/s40266-022-00940-3

Save
Print
June 22, 2022
Lam JYJ, Barras M, Scott IA, et al. Drugs Aging. 2022;39(5):333-353.

Patient characteristics such as age, comorbidities and frailty can increase risk for medication errors. This scoping review shows that studies evaluating medication harm in frail patients are largely limited the methodological quality and inadequate reporting. The authors discuss the need for more robust studies examining this relationship, including the effect of polypharmacy.

Save
Print
Cite
Citation

Lam JYJ, Barras M, Scott IA, et al. Scoping review of studies evaluating frailty and its association with medication harm. Drugs Aging. 2022;39(5):333-353. doi: 10.1007/s40266-022-00940-3